Olympus Corporation
7733.T
Below: live stock price for Olympus Corporation (7733.T), a 1-year chart, 8 indicators (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volume), and a compare mode. Add to your portfolio, star to your watchlist, or set a price alert in one place.
- Prev close
- $12.22
- Volume
- $11.54K
- Market cap
- $13.21B
- Currency
- USD (native JPY)
Financials
- 52w high
- ¥2,168
- 52w low
- ¥1,302.5
- 52w change
- -3.54%
- Day high
- ¥1,882.5
- Day low
- ¥1,840.5
- P/E (TTM)
- 30.19
- Forward P/E
- 14.7
- PEG
- 3.61
- Price / Book
- 2.5
- Beta (5Y)
- 0.19
- Enterprise value
- 2.12T
- EV / Revenue
- 2.1
- EV / EBITDA
- 10.27
- EPS (TTM)
- ¥61.17
- Forward EPS
- ¥125.64
- Dividend yield
- 1.59%
- Dividend rate
- ¥30
- Payout ratio
- 49.02%
- Revenue (TTM)
- 1.01T
- EBITDA
- 206.79B
- Free cash flow
- 1.49B
- Total cash
- 188.04B
- Total debt
- 239.58B
- Debt / Equity
- 29.5
- Current ratio
- 1.62
- Quick ratio
- 1
- Profit margin
- 6.74%
- Gross margin
- 64.72%
- Return on assets
- 5.87%
- Return on equity
- 8.72%
- Shares outstanding
- 1.1B
- Float
- 1.06B
Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.
Analyst & Risk
- Beta (vs S&P 500)
- 0.19
- very stable
- 52-week change
- -3.54%
- Debt / Equity
- 29.5
- very high leverage
- Current ratio
- 1.62
- Quick ratio
- 1
- ROE
- 8.72%
- ROA
- 5.87%
- PEG ratio
- 3.61
- richly valued
- EV / Revenue
- 2.1
- EV / EBITDA
- 10.27
- Revenue growth
- 8.50%
- Earnings growth
- -38.70%
- EBITDA
- 206.79B
- Free cash flow
- 1.49B
- Total cash
- 188.04B
- Total debt
- 239.58B
- Insider holdings
- 4.27%
- Institutional
- 62.34%
Recent news
- Uber reveals an unexpected problem behind the AI boomTheStreet4m ago
- NMAA board approves 'one free transfer' rule; schools get final sayAlbuquerque Journal, N.M.6m ago
- New Mexico's AG files suit against sports betting firm KalshiAlbuquerque Journal, N.M.8m ago
- Why Ollie's (OLLI) Shares Are Sliding TodayStockStory9m ago
- Microsoft Held Up as AI Chips Sold Off. Is It the Safer Megacap Bet Now?Motley Fool10m ago
- Mitsubishi Electric to Launch Data-provision Service to Accelerate Adoption of Latest Power SemiconductorsBusiness Wire11m ago
- Kupcho seizes slim lead in US Women's Open at RivieraAFP12m ago
- Dow Jones Futures: Techs Fall After Dow Hits High, AI Shrugs Off Broadcom, Ciena; Jobs Report LoomsInvestor's Business Daily4m ago
Live discussion
Sign in to join the discussion.
- No comments yet. Be the first.